Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myositis Ossificans | 4 | 2023 | 79 | 2.950 |
Why?
|
| Ossification, Heterotopic | 3 | 2023 | 239 | 1.880 |
Why?
|
| Fibrous Dysplasia, Polyostotic | 2 | 2024 | 36 | 1.830 |
Why?
|
| Niemann-Pick Disease, Type C | 2 | 2023 | 51 | 1.800 |
Why?
|
| Pain | 14 | 2022 | 4986 | 1.380 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 2024 | 54 | 0.930 |
Why?
|
| Neuralgia | 3 | 2024 | 570 | 0.860 |
Why?
|
| Somatosensory Disorders | 1 | 2022 | 47 | 0.820 |
Why?
|
| Osteochondrodysplasias | 1 | 2022 | 183 | 0.790 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2021 | 79 | 0.770 |
Why?
|
| Nerve Net | 5 | 2021 | 2174 | 0.750 |
Why?
|
| Endocrine System Diseases | 1 | 2023 | 248 | 0.750 |
Why?
|
| Brain | 15 | 2021 | 26385 | 0.740 |
Why?
|
| Opioid-Related Disorders | 3 | 2022 | 2065 | 0.720 |
Why?
|
| Pain Measurement | 8 | 2022 | 3420 | 0.640 |
Why?
|
| Neuromuscular Diseases | 1 | 2021 | 248 | 0.630 |
Why?
|
| Reward | 2 | 2021 | 941 | 0.600 |
Why?
|
| Magnetic Resonance Imaging | 28 | 2023 | 35421 | 0.600 |
Why?
|
| Central Nervous System Diseases | 1 | 2021 | 518 | 0.590 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2024 | 2305 | 0.580 |
Why?
|
| Buprenorphine | 4 | 2013 | 640 | 0.580 |
Why?
|
| Activins | 1 | 2017 | 208 | 0.550 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2022 | 4266 | 0.530 |
Why?
|
| Analgesia | 2 | 2017 | 461 | 0.500 |
Why?
|
| Hot Temperature | 4 | 2015 | 1354 | 0.480 |
Why?
|
| Auditory Cortex | 2 | 2008 | 346 | 0.460 |
Why?
|
| Sciatic Neuropathy | 1 | 2013 | 74 | 0.450 |
Why?
|
| Child Abuse | 1 | 2022 | 1030 | 0.440 |
Why?
|
| Executive Function | 1 | 2021 | 1364 | 0.440 |
Why?
|
| Mental Disorders | 2 | 2023 | 6600 | 0.430 |
Why?
|
| Neuropharmacology | 1 | 2011 | 21 | 0.400 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 2104 | 0.390 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2009 | 243 | 0.320 |
Why?
|
| Brain Mapping | 10 | 2018 | 6669 | 0.320 |
Why?
|
| Neural Pathways | 4 | 2021 | 2972 | 0.310 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2008 | 2737 | 0.310 |
Why?
|
| Wakefulness | 2 | 2011 | 1245 | 0.310 |
Why?
|
| Afferent Pathways | 1 | 2008 | 302 | 0.300 |
Why?
|
| Trigeminal Nerve | 1 | 2008 | 249 | 0.290 |
Why?
|
| Analgesics, Opioid | 3 | 2013 | 3674 | 0.280 |
Why?
|
| Analgesics | 2 | 2020 | 1040 | 0.270 |
Why?
|
| Spectrum Analysis | 1 | 2007 | 454 | 0.260 |
Why?
|
| Aspartic Acid | 1 | 2007 | 576 | 0.250 |
Why?
|
| Action Potentials | 1 | 2012 | 1806 | 0.250 |
Why?
|
| Osteoarthritis | 1 | 2012 | 1036 | 0.250 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1889 | 0.240 |
Why?
|
| Brain Stem | 1 | 2008 | 846 | 0.230 |
Why?
|
| Humans | 44 | 2024 | 744343 | 0.220 |
Why?
|
| Corpus Callosum | 1 | 2007 | 737 | 0.220 |
Why?
|
| Sulfonamides | 1 | 2012 | 1938 | 0.220 |
Why?
|
| Pyrazoles | 1 | 2012 | 1972 | 0.210 |
Why?
|
| Inflammation | 1 | 2022 | 10638 | 0.210 |
Why?
|
| Myography | 1 | 2022 | 109 | 0.200 |
Why?
|
| Activin Receptors, Type I | 1 | 2021 | 142 | 0.180 |
Why?
|
| Spinal Cord | 1 | 2008 | 1809 | 0.180 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2015 | 8949 | 0.180 |
Why?
|
| Motor Skills Disorders | 1 | 2020 | 90 | 0.180 |
Why?
|
| Post-Traumatic Headache | 1 | 2021 | 74 | 0.170 |
Why?
|
| Axons | 1 | 2007 | 1684 | 0.170 |
Why?
|
| Models, Neurological | 2 | 2022 | 1774 | 0.170 |
Why?
|
| Putamen | 1 | 2020 | 291 | 0.170 |
Why?
|
| Psychopathology | 1 | 2022 | 409 | 0.170 |
Why?
|
| Electric Impedance | 1 | 2022 | 729 | 0.160 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2008 | 3327 | 0.160 |
Why?
|
| Rare Diseases | 1 | 2023 | 553 | 0.160 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2020 | 124 | 0.160 |
Why?
|
| Child | 6 | 2024 | 77709 | 0.160 |
Why?
|
| Diphosphonates | 1 | 2023 | 623 | 0.160 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 18029 | 0.150 |
Why?
|
| Muscles | 1 | 2022 | 1614 | 0.150 |
Why?
|
| Adult | 16 | 2024 | 214055 | 0.150 |
Why?
|
| Adolescent | 7 | 2023 | 85781 | 0.150 |
Why?
|
| Comorbidity | 2 | 2022 | 10388 | 0.150 |
Why?
|
| Cerebrum | 1 | 2018 | 137 | 0.150 |
Why?
|
| Avoidance Learning | 1 | 2018 | 233 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 3760 | 0.150 |
Why?
|
| Age of Onset | 1 | 2024 | 3271 | 0.150 |
Why?
|
| Lysosomes | 1 | 2021 | 893 | 0.140 |
Why?
|
| Cerebellum | 1 | 2023 | 1488 | 0.140 |
Why?
|
| Prefrontal Cortex | 2 | 2021 | 2147 | 0.140 |
Why?
|
| Central Nervous System | 1 | 2024 | 1357 | 0.140 |
Why?
|
| Drug Design | 2 | 2011 | 1076 | 0.130 |
Why?
|
| Male | 23 | 2022 | 350118 | 0.130 |
Why?
|
| X-Ray Microtomography | 1 | 2017 | 428 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 1017 | 0.130 |
Why?
|
| Phenotype | 2 | 2023 | 16365 | 0.120 |
Why?
|
| Rats | 5 | 2013 | 24260 | 0.120 |
Why?
|
| Autophagy | 1 | 2021 | 1300 | 0.120 |
Why?
|
| Oxygen | 4 | 2015 | 4189 | 0.110 |
Why?
|
| Fluorescence Polarization | 1 | 2013 | 132 | 0.110 |
Why?
|
| Nalbuphine | 1 | 2013 | 20 | 0.110 |
Why?
|
| Acoustic Stimulation | 2 | 2008 | 1216 | 0.110 |
Why?
|
| Knee Joint | 1 | 2021 | 1680 | 0.110 |
Why?
|
| Administration, Sublingual | 1 | 2011 | 56 | 0.100 |
Why?
|
| Bone and Bones | 1 | 2023 | 2575 | 0.100 |
Why?
|
| Cross-Over Studies | 3 | 2013 | 2029 | 0.100 |
Why?
|
| Gyrus Cinguli | 2 | 2023 | 1091 | 0.100 |
Why?
|
| Drug Discovery | 2 | 2017 | 1058 | 0.100 |
Why?
|
| Caregivers | 1 | 2023 | 2094 | 0.100 |
Why?
|
| Pulvinar | 1 | 2011 | 22 | 0.100 |
Why?
|
| Rats, Long-Evans | 1 | 2011 | 387 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 10943 | 0.100 |
Why?
|
| Rats, Inbred Lew | 1 | 2012 | 1162 | 0.090 |
Why?
|
| Touch | 2 | 2010 | 306 | 0.090 |
Why?
|
| Respiratory Rate | 1 | 2011 | 162 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2022 | 8324 | 0.090 |
Why?
|
| Guidelines as Topic | 3 | 2011 | 1405 | 0.090 |
Why?
|
| Clinical Trials as Topic | 3 | 2011 | 7913 | 0.090 |
Why?
|
| Brain Concussion | 1 | 2021 | 1320 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2015 | 2971 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2011 | 1420 | 0.090 |
Why?
|
| Trigeminal Nucleus, Spinal | 1 | 2008 | 18 | 0.080 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2010 | 211 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2024 | 53288 | 0.080 |
Why?
|
| Trigeminal Neuralgia | 1 | 2010 | 113 | 0.080 |
Why?
|
| Young Adult | 5 | 2022 | 56430 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2373 | 0.080 |
Why?
|
| Proteomics | 1 | 2022 | 3638 | 0.080 |
Why?
|
| Neurosciences | 1 | 2013 | 348 | 0.080 |
Why?
|
| Animals | 9 | 2017 | 168757 | 0.080 |
Why?
|
| Triazines | 1 | 2010 | 315 | 0.080 |
Why?
|
| Physical Stimulation | 1 | 2009 | 525 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2013 | 2008 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2013 | 8301 | 0.080 |
Why?
|
| Optic Nerve | 1 | 2011 | 554 | 0.080 |
Why?
|
| Basal Ganglia | 1 | 2010 | 546 | 0.070 |
Why?
|
| Drug Evaluation | 1 | 2008 | 647 | 0.070 |
Why?
|
| Pharmaceutical Preparations | 2 | 2017 | 1071 | 0.070 |
Why?
|
| Parietal Lobe | 1 | 2011 | 838 | 0.070 |
Why?
|
| Visual Pathways | 1 | 2011 | 565 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6365 | 0.070 |
Why?
|
| Hypothalamus | 1 | 2011 | 1063 | 0.070 |
Why?
|
| Diffusion | 1 | 2007 | 833 | 0.070 |
Why?
|
| Female | 10 | 2023 | 380194 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 25043 | 0.070 |
Why?
|
| Ketamine | 1 | 2010 | 500 | 0.060 |
Why?
|
| Double-Blind Method | 3 | 2013 | 12026 | 0.060 |
Why?
|
| Nerve Fibers | 1 | 2006 | 687 | 0.060 |
Why?
|
| Amygdala | 1 | 2010 | 1315 | 0.050 |
Why?
|
| Quality of Life | 1 | 2024 | 12804 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2008 | 941 | 0.050 |
Why?
|
| Probability | 1 | 2006 | 2505 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2008 | 2290 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2010 | 1916 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2023 | 20129 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 19905 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2022 | 41006 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2008 | 1563 | 0.040 |
Why?
|
| Quality Control | 2 | 2011 | 841 | 0.040 |
Why?
|
| Middle Aged | 5 | 2022 | 213383 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2013 | 2274 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 6234 | 0.040 |
Why?
|
| Anxiety | 1 | 2011 | 4297 | 0.040 |
Why?
|
| Hand Strength | 1 | 2020 | 448 | 0.040 |
Why?
|
| Image Enhancement | 1 | 2007 | 2921 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 29786 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 5708 | 0.030 |
Why?
|
| Drug Industry | 2 | 2011 | 746 | 0.030 |
Why?
|
| Software | 1 | 2006 | 4443 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77449 | 0.030 |
Why?
|
| Psychophysics | 1 | 2013 | 309 | 0.030 |
Why?
|
| Receptors, Opioid, mu | 1 | 2013 | 182 | 0.030 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2012 | 129 | 0.030 |
Why?
|
| Photophobia | 1 | 2011 | 67 | 0.020 |
Why?
|
| Mice | 1 | 2017 | 81183 | 0.020 |
Why?
|
| Naloxone | 1 | 2013 | 367 | 0.020 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2011 | 162 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 2010 | 383 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2010 | 280 | 0.020 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2010 | 141 | 0.020 |
Why?
|
| Amines | 1 | 2010 | 276 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 40561 | 0.020 |
Why?
|
| Species Specificity | 1 | 2013 | 2478 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2010 | 772 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 1676 | 0.020 |
Why?
|
| Amino Acids | 1 | 2010 | 1736 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 1121 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2010 | 956 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2010 | 1534 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2010 | 6038 | 0.010 |
Why?
|
| Decision Making | 1 | 2012 | 3887 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2010 | 6196 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 9583 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 13881 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 40075 | 0.000 |
Why?
|
| Aged | 1 | 2020 | 163280 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2010 | 63114 | 0.000 |
Why?
|
| United States | 1 | 2008 | 69872 | 0.000 |
Why?
|
Concepts
(188)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(50)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_